Completed OBSERVATIONAL NCT05908448

The True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus

Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System in Pediatric Patients With Type 1 Diabetes Mellitus: an Open Label, Multi-Center Trial

Sponsor: Atlanta Diabetes Associates

Conditions T1DM - Type 1 Diabetes Mellitus

Interventions 13 CGM (continuous glucose monitor)

Updated 5 times since 2023 Last updated: Dec 2, 2024 Started: Feb 7, 2024 Primary completion: Oct 18, 2024 Completion: Nov 13, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05908448, this observational or N/A phase trial focuses on T1DM - Type 1 Diabetes Mellitus and remains completed. Sponsored by Atlanta Diabetes Associates, it has been updated 5 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jan 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Jan 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Mar 2024 — Jul 2024 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jul 2023 — Mar 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atlanta Diabetes Associates
Sinocare

Data source: Sinocare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Atlanta, United States